2nd GATE PARTNERING EVENT
Researchers from UGent, UZ Gent, imec and VIB will present break-through research on topics of gene and cell therapy, and regenerative medicine. Next to scientific and technological innovation, the event will highlight succesful academic-industry partnerships to advance gene and cell therapy programs towards the clinic. Stakeholders will be invited to give newest insights in the rapidly evolving ATMP landscape in Ghent, Belgium and beyond.
We welcome principal investigators, clinicians and senior postdocs from academia as well as company delegates active in the field of life sciences to join our event and partner with us.
WHAT TO EXPECT
A half day program presenting a selection of collaborative and translational science programs on hot topics in the ATMP field, including:
Session 1: mRNA vaccine development involving successful partnerships with biotech
Session 2: Optogenetic gene therapy for epilepsy
Session 3: Innovation in CAR-T cell production, evaluation and manufacturing
Session 4: Clinical trials for gene and cell therapy
The on-site format provides plenty of opportunities to learn, connect and network with scientists, clinicians, industry innovators and policy makers in the exciting field of ATMP.
SPONSORSHIP OPPORTUNITIES
As sponsor you will have the chance to:
Create visibility for your company through onsite and pre-event advertisement
Network and discuss with some of the leading experts in the field
Showcase your products
Get introduced to the scientific community of Ghent active within the field of organ-on-chip, gene & cell therapies, and regenerative medicine
Contact gudrun.antoons@ugent.be to discuss your sponsorship package
REGISTRATION & FURTHER INFORMATION
Date & Time: 17 March 2023 from 12 to 6 pm
Venue: On-site, Rodebol, Sint-Denijslaan 485, 9000 Gent
Registration: via link https://congrezzo.ugent.be/gate-partnering-2023/
You will find further information on the event’s webpage
https://www.gatehealth.be/news-events/2nd-gate-partnering-event
ABOUT GATE
Regenerative medicine is by nature a multi-disciplinary field, in which innovation management is becoming ever more complex. To meet these increasing challenges, Ghent University, University Hospital Ghent, imec and VIB are joining forces. This led to the foundation of GATE, a virtual institute where researchers and clinicians from various disciplines and expertise work together with innovation professionals to develop faster, more efficient and more market-oriented solutions for regenerative medicine gene therapy, (advanced) cell therapy and tissue regeneration, as well as innovative organ-on-chip technologies for drug development and disease modelling. Our ambition is to cover the complete process from early research to first-in-human clinical trials, realizing the promise of regenerative medicine and advanced therapies.